Celemics Inc (331920)

Currency in KRW
10,270
-1,020(-9.03%)
Delayed Data·
331920 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
9,70011,290
52 wk Range
2,53519,840
Key Statistics
Bid/Ask
10,190.00 / 10,260.00
Prev. Close
11,290
Open
11,290
Day's Range
9,700-11,290
52 wk Range
2,535-19,840
Volume
61.91K
Average Volume (3m)
166.19K
1-Year Change
231.8255%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
331920 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Prominent player in the Life Sciences Tools & Services industry

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Sell
Moving Averages
Strong Sell
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
15/05/2026
EPS / Forecast
-740.70 / --
Revenue / Forecast
923.41M / --
EPS Revisions
Last 90 days

331920 Income Statement

Compare 331920 to Peers and Sector

Metrics to compare
331920
Peers
Sector
Relationship
P/E Ratio
−14.1x−2.6x−0.4x
PEG Ratio
0.070.010.00
Price/Book
6.3x1.6x2.6x
Price / LTM Sales
22.3x3.6x3.1x
Upside (Analyst Target)
-12.3%48.3%
Fair Value Upside
Unlock4.7%6.1%Unlock

Celemics, Inc. designs, manufactures, and distributes sequencing kits in South Korea. The company offers whole exome sequencing panels; NGS target enrichment panels; customized and ready-to-use enrichment panels; and modular accessories, including library preparation kits, double standard Cdna synthesis, hybridization enhancer, celan-up and streptavidin beads, CeleNM beads, and polymerase. It also provides celemics analysis, whole exome sequencing, customized NGS panels, sequencing, bioinformatics, biopharma, and custom NGS assay development services. Its products are used in oncology, liquid biopsy, biopharma solutions, inherited diseases, pharmacogenomics, virus research, agrigenomics, RNA sequencing, epigenetics, metagenomic sequencing, antibody discovery, and bioinformatics applications. The company was founded in 2010 and is headquartered in Seoul, South Korea.

People Also Watch

8,930
001740
-1.43%
43,150
031210
-0.12%
54,400
218410
-6.04%
18,640
214320
-1.01%
176,900
036930
-2.64%

FAQ

What Is the Celemics (331920) Stock Price Today?

The Celemics stock price today is 10,270 KRW.

What Stock Exchange Does Celemics Trade On?

Celemics is listed and trades on the KOSDAQ.

What Is the Stock Symbol for Celemics?

The stock symbol for Celemics is "331920."

What Is the Celemics Market Cap?

As of today, Celemics market cap is 110.61B KRW.

What Is Celemics's Earnings Per Share (TTM)?

The Celemics EPS (TTM) is -960.

From a Technical Analysis Perspective, Is 331920 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Celemics Stock Split?

Celemics has split 0 times.

What is the current trading status of Celemics (331920)?

As of 07/07/2026, Celemics (331920) is trading at a price of 10,270 KRW, with a previous close of 11,290 KRW. The stock has fluctuated within a day range of 9,700 KRW to 11,290 KRW, while its 52-week range spans from 2,535 KRW to 19,840 KRW.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.